Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.

dc.contributor.authorHodcroft, Emma B
dc.contributor.authorZuber, Moira
dc.contributor.authorNadeau, Sarah
dc.contributor.authorVaughan, Timothy G
dc.contributor.authorCrawford, Katharine H D
dc.contributor.authorAlthaus, Christian L
dc.contributor.authorReichmuth, Martina L
dc.contributor.authorBowen, John E
dc.contributor.authorWalls, Alexandra C
dc.contributor.authorCorti, Davide
dc.contributor.authorBloom, Jesse D
dc.contributor.authorVeesler, David
dc.contributor.authorMateo, David
dc.contributor.authorHernando, Alberto
dc.contributor.authorComas, Iñaki
dc.contributor.authorGonzález-Candelas, Fernando
dc.contributor.authorSeqCOVID-SPAIN consortium
dc.contributor.authorStadler, Tanja
dc.contributor.authorNeher, Richard A
dc.date.accessioned2025-01-07T14:09:51Z
dc.date.available2025-01-07T14:09:51Z
dc.date.issued2021-06-07
dc.description.abstractFollowing its emergence in late 2019, the spread of SARS-CoV-21,2 has been tracked by phylogenetic analysis of viral genome sequences in unprecedented detail3-5. Although the virus spread globally in early 2020 before borders closed, intercontinental travel has since been greatly reduced. However, travel within Europe resumed in the summer of 2020. Here we report on a SARS-CoV-2 variant, 20E (EU1), that was identified in Spain in early summer 2020 and subsequently spread across Europe. We find no evidence that this variant has increased transmissibility, but instead demonstrate how rising incidence in Spain, resumption of travel, and lack of effective screening and containment may explain the variant's success. Despite travel restrictions, we estimate that 20E (EU1) was introduced hundreds of times to European countries by summertime travellers, which is likely to have undermined local efforts to minimize infection with SARS-CoV-2. Our results illustrate how a variant can rapidly become dominant even in the absence of a substantial transmission advantage in favourable epidemiological settings. Genomic surveillance is critical for understanding how travel can affect transmission of SARS-CoV-2, and thus for informing future containment strategies as travel resumes.
dc.identifier.doi10.1038/s41586-021-03677-y
dc.identifier.essn1476-4687
dc.identifier.pmid34098568
dc.identifier.unpaywallURLhttps://www.nature.com/articles/s41586-021-03677-y.pdf
dc.identifier.urihttps://hdl.handle.net/10668/26185
dc.issue.number7869
dc.journal.titleNature
dc.journal.titleabbreviationNature
dc.language.isoen
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.organizationSAS - Hospital Universitario San Cecilio
dc.page.number707-712
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, N.I.H., Extramural
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subject.meshCOVID-19
dc.subject.meshEurope
dc.subject.meshGenotype
dc.subject.meshHumans
dc.subject.meshPhylogeny
dc.subject.meshSARS-CoV-2
dc.subject.meshSeasons
dc.subject.meshTime Factors
dc.subject.meshTravel
dc.titleSpread of a SARS-CoV-2 variant through Europe in the summer of 2020.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number595

Files